Impact of weight loss and eating difficulties on health‐related quality of life up to 10 years after oesophagectomy for cancer.
Published: 21st November 2017
Authors: P. Anandavadivelan, A. Wikman, A. Johar, P. Lagergren
Severe weight loss is experienced by patients with eating difficulties after surgery for oesophageal cancer. The aim of this prospective cohort study was to asssess the influence of eating difficulties and severe weight loss on health‐related quality of life (HRQoL) up to 10 years after oesophagectomy.
Data on bodyweight and HRQoL were collected at 6 months, 3, 5 and 10 years in patients who underwent surgery for oesophageal cancer in Sweden between 2001 and 2005. Exposures were percentage weight loss, and eating difficulties defined by the European Organisation for Research and Treatment of Cancer (EORTC) QLQ‐OES18 questionnaire. Outcomes were HRQoL scores from the EORTC QLQ‐C30 questionnaire. Repeated‐measures ANOVA, adjusting for potential confounders, was used to assess the association between eating difficulties and weight loss (4 exposure groups) and HRQoL scores at each time point. Mean score differences (MDs) between time points or exposure groups were defined as clinically relevant in accordance with evidence‐based interpretation guidelines.
In total, 92 of 104 10‐year survivors (88·5 per cent) responded to the questionnaires. Weight loss was greatest within 6 months of surgery. Patients with eating difficulties with or without weight loss reported clinically and statistically significantly worsened HRQoL in almost all aspects. The largest MD was seen between 5 and 10 years after surgery for global quality of life, physical, role and social function (MD –22 to –30), as well for fatigue, nausea, dyspnoea, insomnia, appetite loss and diarrhoea (MD 24–36).
Eating difficulties are associated with deterioration in several aspects of HRQoL up to 10 years after surgery for oesophageal cancer.Read more
You may also be interested in
Comparison of gaze behaviour of trainee and experienced surgeons during laparoscopic gastric bypass.
Authors: S. Erridge, H. Ashraf, S. Purkayastha, A. Darzi, M. H. Sodergren
Notes: Potential uses in training and assessment
Influence of national centralization of oesophagogastric cancer on management and clinical outcome from emergency upper gastrointestinal conditions. BJS 2018; 105: 113-120.
Authors: S. R. Markar, H. Mackenzie, T. Wiggins, A. Askari, A. Karthikesalingam, O. Faiz et al.
Notes: Improves outcome of oesophageal perforation
Meta‐analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer.
Authors: K. Polom, L. Marano, D. Marrelli, R. De Luca, G. Roviello, V. Savelli et al.
Notes: Microsatellite instability subgroup does better
Authors: V. Wanjura, E. Szabo, J. Österberg, J. Ottosson, L. Enochsson, G. Sandblom et al.
Notes: Avoid unnecessary surgery
Meta‐analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer. BJS 2017; 104: 1609-1619.
Authors: B. Creavin, M. E. Kelly, E. Ryan, D. C. Winter
Notes: Open excision provides better‐quality mesorectum
Authors: J. Deng, J. Guo, G. Ma, H. Zhang, D. Sun, Y. Hou et al.
Notes: Identifies a poor prognosis group
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma. BJS 2017; 104: 1816-1828.
Authors: F. Noble, M. A. Lloyd, R. Turkington, E. Griffiths, M. O'Donovan, J. R. O'Neill et al.
Notes: Response associated with survival
Authors: P. Probst, S. Ohmann, U. Klaiber, F. J. Hüttner, A. T. Billeter, A. Ulrich et al.
Notes: Publication bias likely
Randomized clinical trial
Double‐blind randomized clinical trial of percutaneous endoscopic gastrostomy versus radiologically inserted gastrostomy in children. BJS 2017; 104: 1620-1627.
Authors: R. R. Singh, S. A. Nah, D. J. Roebuck, S. Eaton, A. Pierro, J. I. Curry et al.
Notes: No difference in the number or magnitude of complications
Weekend admission and mortality for gastrointestinal disorders across England and Wales. BJS 2017; 104: 1723-1734.
Authors: S. E. Roberts, T. H. Brown, K. Thorne, R. A. Lyons, A. Akbari, D. J. Napier et al.
Notes: Worst for gastrointestinal cancer and liver disease
Use of endoscopy to determine the resection margin during laparoscopic gastrectomy for cancer. BJS 2017; 104: 1829-1836.
Authors: S. Kawakatsu, M. Ohashi, N. Hiki, S. Nunobe, M. Nagino, T. Sano et al.
Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancer. BJS 2017; 104: 1837-1846.
Authors: S. D. Nelen, M. van Putten, V. E. P. P. Lemmens, K. Bosscha, J. H. W. de Wilt, R. H. A. Verhoeven et al.
Notes: Less surgery, more chemotherapy , but no change in survival